文献速递神经肿瘤

脑肿瘤切除术中采集的组织碎片对脂质核心纳米颗粒的摄取:用于药物靶向治疗的假设

Uptake of lipid core nanoparticles by fragments of tissues collected during cerebral tumor excision surgeries: hypotheses for use in drug targeting therapy.
PubMed 文献 · J Neurooncol · 2022-05-25

研究纳入12例脑肿瘤切除术患者,术前12小时静脉注射标记14C-胆固醇油酸酯的脂质纳米颗粒(LDE),检测肿瘤与正常组织碎片放射性。恶性肿瘤LDE摄取为良性肿瘤的三倍(140±93 vs 46±18 d.p.m./g,p<0.05),提示LDE可浓聚于脑恶性肿瘤并可能用于药物靶向。

要点

  • 恶性肿瘤LDE摄取为良性肿瘤的三倍(140±93 vs 46±18 d.p.m./g,p<0.05)。
  • 肿瘤LDE摄取范围10-283 d.p.m./g,不低于正常组织(20-263 d.p.m./g)。
  • 因LDE既往显示可显著降低药物毒性,作者认为该治疗策略应在未来试验中检验。

核心结论

  • LDE可浓聚于脑恶性肿瘤,可能用于携带针对这些肿瘤的药物;因LDE既往显示可显著降低药物毒性,作者认为该新治疗策略应在未来试验中检验。

研究设计与样本

  • 连续纳入12例计划行肿瘤切除术的患者,其中4例胶质母细胞瘤、1例髓母细胞瘤、1例原发性淋巴瘤、2例非脑转移瘤、4例良性肿瘤。
  • 术前12小时静脉注射标记14C-胆固醇油酸酯的LDE,对手术丢弃的肿瘤碎片及正常头部组织(肌肉、骨膜、硬脑膜)碎片进行脂质提取和放射性计数。

主要发现

  • 肿瘤LDE摄取范围为10-283 d.p.m./g组织,不低于正常组织范围20-263 d.p.m./g。
  • 恶性肿瘤LDE摄取为良性肿瘤的三倍(140±93 vs 46±18 d.p.m./g,p<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Malignant cerebral tumors have poor prognosis and the blood-brain barrier is a major hindrance for most drugs to reach those tumors. Lipid nanoparticles (LDE) that bind to lipoprotein receptors may carry anticancer drugs and penetrate the cells through those receptors that are overexpressed in gliomas. The aim was to investigate the in vivo uptake of LDE by human cerebral tumors. METHODS: Twelve consecutive patients (4 with glioblastomas, 1 meduloblastoma, 1 primary lymphoma, 2 with non-cerebral metastases and 4 with benign tumors) scheduled for tumor excision surgery were injected intravenously, 12 h before surgery, with LDE labeled 14C-cholesterol oleate. Fragments of tumors and of normal head tissues (muscle, periosteum, dura mater) discarded by the surgeon were submitted to lipid extraction and radioactive counting. RESULTS: Tumor LDE uptake (range: 10-283 d.p.m./g of tissue) was not lower than that of normal tissues (range: 20-263 d.p.m./g). Malignant tumor uptake was threefold greater than benign tumor uptake (140 ± 93 vs 46 ± 18 d.p.m./g, p < 0.05). Results show that LDE can concentrate in brain malignant tumors and may be used to carry drugs directed against those tumors. CONCLUSION: As LDE was previously shown to markedly decrease drug toxicity this new therapeutic strategy should be tested in future trials.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Pereira ELR, Feio DCA, Tavares JPL, et al. Uptake of lipid core nanoparticles by fragments of tissues collected during cerebral tumor excision surgeries: hypotheses for use in drug targeting therapy. J Neurooncol. 2022. PMID: 35612697. doi:10.1007/s11060-022-04028-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。